![Christopher D. Earl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher D. Earl
Präsident bei
Innotrove LLC
Profil
Christopher D.
Earl is currently the Director at Asuragen, Inc. and the President at Innotrove LLC.
He previously worked as the President & Chief Executive Officer at Avitech Diagnostics, Inc. and as a Director at Replidyne, Inc., Daktari Diagnostics, Inc., AdvanDx, Inc., Mirna Therapeutics, Inc., and Decipher Biosciences, Inc. He was also the Managing Director at Perseus Capital, Inc. and the President at Bio Ventures for Global Health from 2010 to 2013.
Earl holds a doctorate degree from Harvard University and an undergraduate degree from the University of Pennsylvania.
Aktive Positionen von Christopher D. Earl
| Unternehmen | Position | Beginn |
|---|---|---|
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Direktor/Vorstandsmitglied | 16.05.2011 |
Innotrove LLC
 Innotrove LLC Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Präsident | - |
Ehemalige bekannte Positionen von Christopher D. Earl
| Unternehmen | Position | Ende |
|---|---|---|
Replidyne, Inc.
 Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Direktor/Vorstandsmitglied | 27.03.2008 |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Direktor/Vorstandsmitglied | - |
AdvanDx, Inc.
 AdvanDx, Inc. Medical SpecialtiesHealth Technology Provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections | Direktor/Vorstandsmitglied | - |
Daktari Diagnostics, Inc.
 Daktari Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops point-of-care diagnostic systems for global health applications | Direktor/Vorstandsmitglied | - |
Perseus Capital, Inc.
 Perseus Capital, Inc. Investment ManagersFinance Provides investment management services | Vorstandsvorsitzender | - |
Ausbildung von Christopher D. Earl
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
Daktari Diagnostics, Inc.
Daktari Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops point-of-care diagnostic systems for global health applications | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avitech Diagnostics, Inc.
 Avitech Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacogenetic drug development and drug discovery | Health Technology |
Bio Ventures for Global Health
 Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | |
Perseus Capital, Inc.
Perseus Capital, Inc. Investment ManagersFinance Provides investment management services | Finance |
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology Provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections | Health Technology |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Commercial Services |
Innotrove LLC
Innotrove LLC Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
